Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Nearly 100% of cancer patients with solid tumours have antibodies effective against the Delta variant after a third dose of COVID-19 vaccine, according to new results published in Cancer Cell.
23 Dec 2021
United Kingdom
Research buzz

To view this News Article please log in or create a profile

Similar stories

Researchers have shown that the transfer of genes from bacteria into more complex organisms can give them an advantage but requires remodelling of the host’s biology. More...

Researchers have developed polymer water channels, similar to commonly used plastics, that can draw salt out of water, i… More...

Researchers at the Crick have demonstrated that a genetic method called ‘pooled prime editing’ can screen hundreds of va… More...

Researchers at the Crick have identified genetic changes in blood stem cells from frequent blood donors that support the… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk